NCT07019012View on ClinicalTrials.gov

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

PHASE4RecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

December 30, 2026

Conditions
T2DM
Interventions
DRUG

SGLT2i+Metformin+Cofrogliptin

The combination of SGLT2i+Metformin+Cofrogliptin

DRUG

SGLT2i+Metformin+Linagliptin

The combination of SGLT2i+Metformin+Linagliptin

Trial Locations (2)

Unknown

RECRUITING

Wuhan University People's Hospital, Wuhan

RECRUITING

Wuhan University People's Hospital, Wuhan

All Listed Sponsors
collaborator

Renmin Hospital of Wuhan University

OTHER

collaborator

Wuhan Central Hospital

OTHER

collaborator

Taihe Hospital

OTHER

collaborator

Xiangyang No.1 People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Nanchang University

OTHER

lead

Huazhong University of Science and Technology

OTHER